BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36431178)

  • 1. Bone Loss in Patients with Pancreatic Neuroendocrine Tumors.
    Tong H; Wang M; Liu J; Guo C; Wang Z; Wang J; Chen X
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proximal Femur Hounsfield Units on CT Colonoscopy Correlate With Dual-energy X-ray Absorptiometry.
    Christensen DL; Nappo KE; Wolfe JA; Wade SM; Brooks DI; Potter BK; Forsberg JA; Tintle SM
    Clin Orthop Relat Res; 2019 Apr; 477(4):850-860. PubMed ID: 30811362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunistic osteoporosis screening using routine computed tomography images to identify bone loss in gynecologic cancer survivors.
    Sobecki J; Weigman B; Anderson-Carter I; Barroilhet L; Chandereng T; Kliewer M; Hartenbach E
    Int J Gynecol Cancer; 2022 Aug; 32(8):1050-1055. PubMed ID: 35101963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
    Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
    Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Differentiation of Pancreatic Neuroendocrine Tumor From Other Neoplastic Solid Pancreatic Lesions During Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
    Krishna SG; Bhattacharya A; Li F; Ross WA; Ladha H; Porter K; Atiq M; Bhutani MS; Lee JH
    Pancreas; 2016 Mar; 45(3):394-400. PubMed ID: 26418912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
    Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
    AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
    [No Abstract]   [Full Text] [Related]  

  • 9. Differentiation of solid-pseudopapillary tumors of the pancreas from pancreatic neuroendocrine tumors by using endoscopic ultrasound.
    Liu Y; Shi S; Hua J; Xu J; Zhang B; Liu J; Yang XJ; Yu XJ
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):947-953. PubMed ID: 32144073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunistic screening for osteoporosis and osteopenia by routine computed tomography scan: A heterogeneous, multiethnic, middle-eastern population validation study.
    Cohen A; Foldes AJ; Hiller N; Simanovsky N; Szalat A
    Eur J Radiol; 2021 Mar; 136():109568. PubMed ID: 33545629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing the Undiagnosed: Osteoporosis in Patients Undergoing Lumbar Fusion.
    Wagner SC; Formby PM; Helgeson MD; Kang DG
    Spine (Phila Pa 1976); 2016 Nov; 41(21):E1279-E1283. PubMed ID: 27802255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality imaging differentiation of pancreatic neuroendocrine tumors and solid pseudopapillary tumors with a nomogram model: A large single-center study.
    Hu HF; Li Z; Chen K; Liu MQ; Ye Z; Chen XM; Zhang Y; Yu XJ; Xu XW; Ji SR
    Front Surg; 2022; 9():970178. PubMed ID: 36277293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vertebral fracture prevalence and measurement of the scanographic bone attenuation coefficient on CT-scan in patients with systemic sclerosis.
    Fauny M; Bauer E; Albuisson E; Perrier-Cornet J; Deibener J; Chabot F; Mandry D; Huttin O; Chary-Valckenaere I; Loeuille D
    Rheumatol Int; 2018 Oct; 38(10):1901-1910. PubMed ID: 30132216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of IV contrast on lumbar trabecular attenuation at routine abdominal CT: correlation with DXA and implications for opportunistic osteoporosis screening.
    Pickhardt PJ; Lauder T; Pooler BD; Muñoz Del Rio A; Rosas H; Bruce RJ; Binkley N
    Osteoporos Int; 2016 Jan; 27(1):147-52. PubMed ID: 26153046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
    Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
    Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications.
    Pickhardt PJ; Pooler BD; Lauder T; del Rio AM; Bruce RJ; Binkley N
    Ann Intern Med; 2013 Apr; 158(8):588-95. PubMed ID: 23588747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic screening for osteoporosis in abdominal computed tomography for Chinese population.
    Li YL; Wong KH; Law MW; Fang BX; Lau VW; Vardhanabuti VV; Lee VK; Cheng AK; Ho WY; Lam WW
    Arch Osteoporos; 2018 Jul; 13(1):76. PubMed ID: 29987388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of contrast-enhanced computed tomography for the differential diagnosis of hypovascular pancreatic neuroendocrine tumors from chronic mass-forming pancreatitis.
    Ren S; Qian L; Daniels MJ; Duan S; Chen R; Wang Z
    Eur J Radiol; 2020 Dec; 133():109360. PubMed ID: 33126171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes Is Associated With the Metastasis of Pancreatic Neuroendocrine Tumors.
    Fan Z; Gong Y; Huang Q; Yang C; Cheng H; Jin K; Fan K; Ni Q; Yu X; Luo G; Liu C
    Pancreas; 2020 Jul; 49(6):751-756. PubMed ID: 32541629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma.
    Kim JH; Eun HW; Kim YJ; Lee JM; Han JK; Choi BI
    Eur Radiol; 2016 May; 26(5):1338-47. PubMed ID: 26253257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.